Senior QA Inspector - Finishing Line (2nd Shift)

Simtra BioPharma Solutions; Bloomington (IN); On-site; USD 65,000 - 90,000; Full time

Benefits offered by this job

Medical & Dental Coverage

401(k) Retirement Savings Plan with 2%

Time Off Program

Education Assistance Program

Employee Assistance Program

Job summary

Simtra BioPharma Solutions in Bloomington, IN seeks a Sr. Quality Inspector for Line Operations (2nd shift). You will ensure GMP products meet AQL standards on finishing lines, and make risk-based quality decisions to uphold SISPQ.

The role focuses on online quality control, packaging verifications, and cross-training across QA roles. The 2nd shift runs Monday to Friday, 2:45 PM–11:15 PM, with a broad benefits package and opportunities to contribute to continuous improvement in a cGMP

Qualifications

• High School diploma or GED required.
• Minimum 2 years of pharmaceutical or biotech experience.
• Proficient with MS Word, Excel, Outlook and ERP systems.

Responsibilities

• Monitor product quality through the performance of AQL inspections.
• Perform unit and packaging level visual inspections to ensure conformance with specifications.
• Perform required calculations for AQL Sampling Plans based on ANSI Standards.
• Provide Quality Assurance support on the production lines.
• Crosstrain on QA Label Control and QA Warehouse Technician tasks and other cross training as deemed by management.

Skills

Quality Assurance

AQL Inspections

GMP Compliance

Microsoft Office

Education

High School Diploma

Tools

D365

Veeva

ROBAR

Job description

Simtra BioPharma Solutions in Bloomington, IN seeks a Sr. Quality Inspector for Line Operations (2nd shift). You will ensure GMP products meet AQL standards on finishing lines, and make risk-based quality decisions to uphold SISPQ.

The role focuses on online quality control, packaging verifications, and cross-training across QA roles. The 2nd shift runs Monday to Friday, 2:45 PM–11:15 PM, with a broad benefits package and opportunities to contribute to continuous improvement in a cGMP